EFFECT OF MAVACAMTEN ON HEALTH STATUS IN CHINESE PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: RESULTS FROM THE EXPLORER-CN STUDY

被引:0
|
作者
Tian, Zhuang [1 ]
Li, Liwen [1 ]
Li, Xiaoyan [1 ]
Wang, Jianan [1 ]
Zhang, Qing [1 ]
Li, Zhanquan [1 ]
Peng, Daoquan [1 ]
Yang, Ping [1 ]
Ma, Wei [1 ]
Wang, Fang [1 ]
Jin, Wei [1 ]
Cheng, Xiang [1 ]
Humphries, Michael John [1 ]
Wang, Luojun [1 ]
Fu, Yiqun [1 ]
Zhang, Shuyang [1 ]
机构
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1284-132
引用
收藏
页码:494 / 494
页数:1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF MAVACAMTEN FOR THE TREATMENT OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM) IN FRANCE
    Cotte, F. E.
    Hurst, M.
    Akarkoub, S.
    Ho, M.
    Vernon, J.
    Chambry, L.
    Vega, V.
    Leproust, S.
    VALUE IN HEALTH, 2024, 27 (12) : S64 - S64
  • [22] Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM
    Arnold, Suzanne V.
    Gosch, Kensey L.
    Dolan, Chantal
    Fine, Jennifer T.
    Masri, Ahmad
    Saberi, Sara
    Wang, Andrew
    Elliott, Perry M.
    Hegde, Sheila M.
    Lam, Jenny
    Sehnert, Amy J.
    Cresci, Sharon
    Bach, Richard G.
    Spertus, John A.
    CIRCULATION, 2024, 150 (19) : 1560 - 1562
  • [23] The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients
    DeVries, J. Hans
    Irs, Alar
    Hillege, Hans L.
    EUROPEAN HEART JOURNAL, 2023, 44 (37) : 3492 - 3494
  • [24] Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
    Spertus, John A.
    Fine, Jennifer T.
    Elliott, Perry
    Ho, Carolyn Y.
    Olivotto, Jacopo
    Saberi, Sara
    Li, Wanying
    Dolan, Chantal
    Reaney, Matthew
    Sehnert, Amy J.
    Jacoby, Daniel
    LANCET, 2021, 397 (10293): : 2467 - 2475
  • [25] Effect of Mavacamten on Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study
    Cremer, Paul C.
    Geske, Jeffrey B.
    Owens, Anjali T.
    Jaber, Wael A.
    Harb, Serge C.
    Saberi, Sara
    Wang, Andrew
    Naidu, Srihari S.
    Schaff, Hartzell V.
    Smedira, Nicholas G.
    Wang, Quing
    Lampl, Kathy
    Sehnert, Amy J.
    Nissen, Steven E.
    Desai, Milind Y.
    CIRCULATION, 2022, 146
  • [26] LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY
    Masri, Ahmad
    Lester, Steven J.
    Stendahl, John
    Hegde, Sheila M.
    Sehnert, Amy
    Balaratnam, Ganesh
    Fox, Shawna
    Wang, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 346 - 346
  • [27] Association Of Body Mass Index With Hemodynamic Outcomes In Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
    Boakye, Ellen
    Duqueney, Estherland
    Marzolf, Amy
    Hornsby, Nicole
    DE Feria, Alejandro
    Reza, Nosheen
    Owens, Anjali
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [28] Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study
    Masri, Ahmad
    Lester, Steven J.
    Stendahl, John C.
    Hegde, Sheila M.
    Sehnert, Amy J.
    Balaratnam, Ganesh
    Shah, Ashish
    Fox, Shawna
    Wang, Andrew
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (08):
  • [29] Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort
    Jhawar, Nikita
    Schneider, Artur
    Hodge, David
    El Sabbagh, Abdallah
    Grogan, Martha
    Nkomo, Vuyisile
    Dispenzieri, Angela
    Rosenthal, Julie
    Nicolau, Jose Nativi
    Leoni-Moreno, Juan Carlos
    Sher, Taimur
    Lyle, Melissa
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 265 - 266
  • [30] Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy Results From SEQUOIA-HCM
    Sherrod, Charles F.
    Saberi, Sara
    Nassif, Michael E.
    Claggett, Brian L.
    Coats, Caroline J.
    Garcia-Pavia, Pablo
    Januzzi, James L.
    Lewis, Gregory D.
    Ma, Changsheng
    Maron, Martin S.
    Miao, Zi Michael
    Olivotto, Iacopo
    Veselka, Josef
    Butzner, Michael
    Jacoby, Daniel L.
    Heitner, Stephen B.
    Kupfer, Stuart
    Malik, Fady I.
    Meng, Lisa
    Wohltman, Amy
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (19) : 1773 - 1785